A scientist putting capsules in a capsule tray in the lab

Get in the Clinic Faster with a Simplified Formulation Strategy

Quickly Achieve Your Clinical Milestones with a Fit-for-Purpose Formulation 

From preclinical and first-in-human (FIH) dosage forms like powder-in-capsule (PIC) and powder-in-bottle (PIB), to optimized drug products for late stage development and market, we offer you a comprehensive and tailored formulation development service. Operating from our state-of-the-art facilities in the U.S. and U.K. and a with global team of over 300 formulation and analytical scientists, we work with you to develop the most appropriate formulation based on the physicochemical and biopharmaceutics properties of your molecule. 

Featured case study

Supporting a U.S. Biotech with DCS classification and product development of an NCE to rapidly achieve first-in-human

When a U.S. Biotech company wanted to determine the DCS (Developability Classification System) designation for their small molecule, they approached Quotient Sciences for a tailored formulation development program to quickly go from preclinical to first-in-human. 

Download Case Study

Learn how we can help you get in the clinic, fast, with formulations developed as either powder-in-capsules (PIC) or powder-in-bottle (PIB). Contact us today to discuss your next project.

Let's Discuss Your Program

Formulation development underpinned by biopharmaceutics & clinical knowledge


Quotient Sciences has more than 30 years of experience developing a breadth of formulations for small molecules and peptides, across a range of indications.  With expertise in simple and complex dosage forms, we have formulated over 1,500 molecules. Our unique track record in clinical research, means we know what it takes to develop formulations across the full development pathway from preclinical to late stage.

Want to know more about our formulation capabilities? Access our info sheet

Have a formulation question?

Chat with our experts directly
  • Dr. Andrew Lewis

    Global VP, Integrated Pharmaceutical Sciences

  • Dr. Nazim Kanji

    Executive Director, Pediatric Services

  • Asma Patel - Vice President, Integrated Development Services at Quotient Sciences

    Dr. Asma Patel

    VP, Integrated Development Services

  • Dr. Alison Wilby

    Director, Modelling & Simulation

  • Helen Baker

    Director, Pharmaceutical Sciences

Thank you for getting in touch with us.

We will send you a reply in the next 48 hours.
If you have not heard from us in the next 48 hours, do not hesitate to call us on:
UK +44 (0)115 974 9000 / US +1-800-769-3518

Ask questions to our scientific team

And finally your details